• This topic is empty.
Viewing 0 reply threads
  • Author
    • #14821

      Eloxx Pharmaceuticals says that it expects to report in the first half of 2020 its topline data from Phase 2 trials testing ELX-02 for cystic fibrosis. Read more here.

      What did you think of this article?

Viewing 0 reply threads
  • You must be logged in to reply to this topic.

©2022 KLEO Template a premium and multipurpose theme from Seventh Queen


We're not around right now. But you can send us an email and we'll get back to you, asap.


Log in with your credentials


Forgot your details?

Create Account

Verify you are not a robot